By Canadian Press

Johnson & Johnson says COVID-19 vaccine 85 per cent effective against severe illness

Jan 29, 2021 | 8:06 AM

OTTAWA — American pharmaceutical giant Johnson and Johnson says its vaccine is very good at preventing people from being hospitalized or dying from COVID-19.

The vaccine is the first to use just a single dose and can be stored in a fridge for up to three months, making it a potential game changer in the COVID-19 vaccination campaign.

The results aren’t quite as good as those seen in the two vaccines Health Canada has already approved, with both Pfizer-BioNTech and Moderna saying their vaccines showed 95 per cent efficacy against severe illness.

Johnson and Johnson says it’s single-dose vaccine is 85 per cent effective against severe illness a month after the injection is given, and 66 per cent effective against both moderate and severe illness.

The federal government has already pre-purchased 10 million doses of the vaccine, but it is still being reviewed by Health Canada.

final flight

Massive Philippine Mars waterbomber preparing for final Island departure

2h ago

Skatepark refresh

Town of Ladysmith seeks public insight in reforming skateboard park

16h ago

stabbing

UPDATE: Two people stab City of Nanaimo employee with needles at Maffeo Sutton Park

19h ago

There is no timeline yet for when approval might come or when those doses would be delivered for use in Canada.

This report by The Canadian Press was first published Jan. 29, 2021.

The Canadian Press